A salvage chemotherapy of R-P-IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R-CHOP therapy as first-line che
about
A salvage chemotherapy of R-P-IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R-CHOP therapy as first-line che
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
A salvage chemotherapy of R-P- ...... CHOP therapy as first-line che
@en
A salvage chemotherapy of R-P- ...... CHOP therapy as first-line che
@nl
type
label
A salvage chemotherapy of R-P- ...... CHOP therapy as first-line che
@en
A salvage chemotherapy of R-P- ...... CHOP therapy as first-line che
@nl
prefLabel
A salvage chemotherapy of R-P- ...... CHOP therapy as first-line che
@en
A salvage chemotherapy of R-P- ...... CHOP therapy as first-line che
@nl
P2093
P2860
P356
P1476
A salvage chemotherapy of R-P- ...... CHOP therapy as first-line che
@en
P2093
Hiroshi Nakamura
Hisashi Tsurumi
Hisataka Moriwaki
Junichi Kitagawa
Michio Sawada
Nobuhiko Nakamura
Nobuhiro Kanemura
Senji Kasahara
Soranobu Ninomiya
P2860
P304
P356
10.1002/HON.2285
P577
2016-03-21T00:00:00Z